Dose-Escalating Study of Pfs230D1 in Combination With R21 in Matrix-M in African Adults

NCT06507605 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention of Malaria Transmission and Clinical Malaria

Interventions

BIOLOGICAL: R21
BIOLOGICAL: Pfs230D1-CRM197
BIOLOGICAL: Pfs230D1-EPA
OTHER: Matrix-M

Sponsor

Serum Institute of India Pvt. Ltd.

Collaborators

[object Object]